Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2300019	人干扰素α2b阴道泡腾胶囊	Recombinant Human Interferon α2b	Capsule	Biological Products(原2)	Supplementary Application	2023-01-29		Shanghai Huaxin High Biotechnology Inc			view
CXSL2200281	人干扰素α2b阴道泡腾胶囊	Recombinant Human Interferon α2b	Capsule	Biological Products(2.2)	New Drug Application	2022-06-20		Kexing Biopharm Co Ltd			view
CXSB2000077	重组人干扰素α2b阴道泡腾胶囊	Recombinant Human Interferon α2b	Capsule	Biological Products(原2)	Supplementary Application	2020-10-20	上海华新生物高技术有限公司	Shanghai Huaxin High Biotechnology Inc	Certificate Completed-Pending Issued	2021-12-20	view
CYSB1300017	重组人干扰素α2b阴道泡腾胶囊	Recombinant Human Interferon α2b	Capsule	Biological Products	Supplementary Application	2013-03-15	上海华新生物高技术有限公司	Shanghai Huaxin High Biotechnology Inc	Certificate Issued	2014-07-24	view
X0300232	重组人干扰素α-2b阴道泡腾胶囊	Recombinant Human Interferon α2b	Capsule	Biological Products(13)	New Drug Application	2003-09-18	上海华新生物高技术有限公司	Shanghai Huaxin High Biotechnology Inc	Certificate Issued	2004-08-10	view